Endpoint definition
↥| Name | I9_HEARTFAIL_AND_ANTIHYPERT |
|---|---|
| Long name | Heart failure and antihypertensive medication |
| Conditions required | RX_ANTIHYP |
| Include | I9_HEARTFAIL |
| First defined in version | DF5 |
| Name | I9_HEARTFAIL_AND_ANTIHYPERT |
|---|---|
| Long name | Heart failure and antihypertensive medication |
| Conditions required | RX_ANTIHYP |
| Include | I9_HEARTFAIL |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 22113 | 10443 | 11670 |
| Unadjusted prevalence (%) | 10.19 | 8.50 | 12.40 |
| Mean age at first event (years) | 65.74 | 65.71 | 65.77 |
| Case fatality at 5-years (%) | 12.02 | 9.40 | 14.35 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 4.0 | 4.0 | 5.0 |
| Recurrence at 6 months (%) | 64.61 | 61.66 | 67.69 |
before Heart failure and antihypertensive medication
after Heart failure and antihypertensive medication
Loading survival analyses plot…
Loading survival analyses table…